Pharmacokinetics of Octreotide in Patients With Cirrhosis and Portal Hypertension; Relationship Between the Plasma Levels of the Analogue and the Magnitude and Duration of the Reduction in Corrected Wedged Hepatic Venous Pressure release_w3uqnv6sf5ajno3yqufpcma5uu

by S. A. Jenkins, D. M. Nott, J. N. Baxter

Cited By

References to this release by other works.
Fuzzy reference matching is a work in progress!
Read more about quality, completeness, and caveats in the fatcat guide.
Showing 1 - 14 of 14 references (in 128ms)

via crossref
Approach to Suspected Variceal Bleeding [chapter]
Kapil Sharma, Shiv K. Sarin
2016   GI Endoscopic Emergencies

via crossref
Variations of pharmacokinetics of drugs in patients with cirrhosis
MA Pena, JF Horga, P Zapater
2016   Expert Review of Clinical Pharmacology
doi:10.1586/17512433.2016.1135733  pmid:26696448 

via crossref
Worldwide practices for pharmacologic therapy in esophageal variceal hemorrhage
Robert S Rahimi, Prathima Guntipalli, Don C Rockey
2013   Scandinavian Journal of Gastroenterology
doi:10.3109/00365521.2013.850736  pmid:24295524 

via crossref
Gastrointestinal Bleeding in Cirrhotic Patients with Portal Hypertension
Erwin Biecker
2013   ISRN Hepatology
doi:10.1155/2013/541836  pmcid:PMC4890899  pmid:27335828 [PDF]

via crossref
Portal Hypertension [chapter]
Riccardo Superina
2012   Pediatric Surgery

via crossref
Acute esophageal variceal bleeding: Current strategies and new perspectives
Salvador Augustin
2010   World Journal of Hepatology
doi:10.4254/wjh.v2.i7.261  pmcid:PMC2998973  pmid:21161008 [PDF]

via fatcat-pubmed
Current management of the complications of portal hypertension: variceal bleeding and ascites
N. Dib
2006   CMAJ - Canadian Medical Association Journal
doi:10.1503/cmaj.051700  pmcid:PMC1455434  pmid:16682712 [PDF]

via crossref
Somatostatin receptor expression, tumour response and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide
J Cebon, None
2006   British Journal of Cancer
doi:10.1038/sj.bjc.6603325  pmcid:PMC2360532  pmid:16953241 [PDF]

via crossref
Lanreotide on Collateral Response to Endothelin-1 and Vasopressin in Cirrhotic Rats
Hui-Chun Huang, Sun-Sang Wang, Fa-Yauh Lee, Full-Young Chang, Han-Chieh Lin, Ming-Chieh Hou, Ying-Ying Yang, Shou-Dong Lee
2006   Journal of the Chinese Medical Association
doi:10.1016/s1726-4901(09)70281-3  pmid:17051749 [PDF]

via crossref
A critical comparison of drug therapies in currently used therapeutic strategies for variceal haemorrhage
F. Nevens
2004   Alimentary Pharmacology and Therapeutics
doi:10.1111/j.1365-2036.2004.02110.x  pmid:15335394 

via crossref
Comment traiter une hémorragie digestive aiguë par rupture de varices oesophagiennes
Aurélie Plessier
2004   Gastroentérologie Clinique et Biologique
doi:10.1016/s0399-8320(04)95236-0  pmid:15150493 

via crossref
Effect of propranolol and depot lanreotide SR on postprandial and circadian portal haemodynamics in cirrhosis
P. Schiedermaier, L. Koch, B. Stoffel-Wagner, G. Layer, T. Sauerbruch
2003   Alimentary Pharmacology and Therapeutics
doi:10.1046/j.1365-2036.2003.01682.x  pmid:14535870 

via crossref
Somatostatin and analogues in portal hypertension
Juan G. Abraldes, Jaime Bosch
2002   Hepatology
doi:10.1053/jhep.2002.33469  pmid:12029614 

via fatcat-crossref
Effects of different octreotide dosages on splanchnic hemodynamics and glucagon in patients with TIPS
Peter Schiedermaier, Burkhard Göke, Tilman Sauerbruch
2001   American Journal of Gastroenterology
doi:10.1111/j.1572-0241.2001.03960.x  pmid:11467656